Our study showed that a panel of IHC markers, including BAP1, mTAP, CD117, and TdT can aid in predicting the vast majority of thymic carcinomas and epithelial cell-rich thymomas, including types A and B3 thymomas and MNTLS. Here, DNTT is linked to thymoma.